These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16734978)

  • 21. Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres.
    Kirby DJ; Rosenkrands I; Agger EM; Andersen P; Coombes AG; Perrie Y
    J Drug Target; 2008 Aug; 16(7):543-54. PubMed ID: 18686124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.
    Amorij JP; Saluja V; Petersen AH; Hinrichs WL; Huckriede A; Frijlink HW
    Vaccine; 2007 Dec; 25(52):8707-17. PubMed ID: 17996993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles.
    Salman HH; Gamazo C; Agüeros M; Irache JM
    Vaccine; 2007 Nov; 25(48):8123-32. PubMed ID: 18029067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance.
    Ando T; Hatsushika K; Wako M; Ohba T; Koyama K; Ohnuma Y; Katoh R; Ogawa H; Okumura K; Luo J; Wyss-Coray T; Nakao A
    J Allergy Clin Immunol; 2007 Oct; 120(4):916-23. PubMed ID: 17606291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
    Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
    Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5.
    Portocarrero C; Markley K; Koprowski H; Spitsin S; Golovkin M
    Vaccine; 2008 Oct; 26(43):5535-40. PubMed ID: 18706953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.
    Salman HH; Irache JM; Gamazo C
    Vaccine; 2009 Jul; 27(35):4784-90. PubMed ID: 19539576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of intranasally administered archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) vaccine in mice.
    Patel GB; Ponce A; Zhou H; Chen W
    Int J Toxicol; 2008; 27(4):329-39. PubMed ID: 18821397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
    Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE
    Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan microspheres containing Bordetella bronchiseptica antigens as novel vaccine against atrophic rhinitis in pigs.
    Kang ML; Kang SG; Jiang HL; Guo DD; Lee DY; Rayamahji N; Seo YS; Cho CS; Yoo HS
    J Microbiol Biotechnol; 2008 Jun; 18(6):1179-85. PubMed ID: 18600065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
    Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
    Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio].
    Dong C; Dai X; Meng JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration.
    Caputo A; Castaldello A; Brocca-Cofano E; Voltan R; Bortolazzi F; Altavilla G; Sparnacci K; Laus M; Tondelli L; Gavioli R; Ensoli B
    Vaccine; 2009 Jun; 27(27):3605-15. PubMed ID: 19464541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rat model of captopril immunogenicity.
    Foster AL; Coleman JW
    Clin Exp Immunol; 1989 Jan; 75(1):161-5. PubMed ID: 2467767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats.
    Liu GX; Xu QA; Jin J; Li YH; Jia R; Guo JH; Fan MW
    Vaccine; 2009 May; 27(22):2940-7. PubMed ID: 19428904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses.
    Kayamuro H; Abe Y; Yoshioka Y; Katayama K; Nomura T; Yoshida T; Yamashita K; Yoshikawa T; Kawai Y; Mayumi T; Hiroi T; Itoh N; Nagano K; Kamada H; Tsunoda S; Tsutsumi Y
    Biomaterials; 2009 Oct; 30(29):5869-76. PubMed ID: 19646748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.